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ABSTRACT 
 
Background 
Activity monitoring devices are currently being tested to facilitate and monitor physical activity. No 
prior reviews have examined adherence to the use of activity monitoring devices amongst adults with 
cardiovascular disease.  
 
Methods 
Literature from June 2012 to October 2017 was evaluated to examine the extent of adherence to any 
activity monitoring device used to collect objective physical activity data. RCTs comparing usual care 
against an activity monitoring device in a community intervention for adults from any cardiovascular 
diagnostic group were included. A systematic search of databases and clinical trials registers was 
conducted using Joanna Briggs Institute methodology.  
 
Results 
Of the ten eligible studies, two studies reported on pedometer use, and eight on accelerometers. Six 
studies addressed our primary outcome with a mean adherence of 59.1% at last follow up; range 
39.6% to 85.7% at six months. Studies lacked equal representation by gender (28.6% female) and age 
(range 42 to 82 years).   
 
Conclusion 
The results of this review have demonstrated we may be over stating results from current research due 
to adherence issues. Results showed physical activity tracking in women and young adults have been 
understudied. 
 
Funding: This study was funded by a National Heart Foundation of Australia Vanguard Grant, 
Award ID 101443 and supported by a Heart Foundation Future Leader Fellowship (App ID: 100847).  
Protocol registration number: CRD42018094781.  
 
KEYWORDS: Adherence, Activity monitoring device, Accelerometer, Pedometers 
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INTRODUCTION 
Rationale 
Cardiovascular disease (CVD) remains the leading cause of death and disability globally and is a 
significant burden on healthcare systems.1, 2 In 2015, it was estimated that 17.7 million people died 
from CVD, representing 31% of all global deaths.2 Although, historically, women have been under-
represented in cardiac care,3, 4 men and women experience the same rates of CVD.2 
Practitioners have long recognized the importance of physical activity (PA) for the maintenance of 
good health and the prevention of chronic diseases, such as CVD.5 Returning to activities of daily 
living and maximizing physical capacity is an important component of the cardiac rehabilitation 
process.6 Initiation of PA, along with the uptake of other risk factor modifications, is highly beneficial 
to the treatment and ongoing maintenance of CVD.6, 7 
Activity monitoring devices and smartphone applications are a cost-effective alternative to promoting 
PA and such devices, designed to improve PA in adults with CVD and other chronic conditions, are 
currently being tested.8-11 Additionally, activity monitoring devices have been shown to affect PA 
behavior change.12-14 These technologies overcome limitations associated with traditional in-person 
exercise programs that often have costly resource and labor requirements and are time intensive.15 
Despite the emergence of accelerometer technology in the 1950s and its increasing use in the 1970s as 
the technology advanced,16 it is only in the more recent years that activity tracking devices have 
become truly wearable, accessible and portable with minimal inconvenience to the user.  
To understand whether interventions using such devices have been effective, we need to not only 
identify whether behavior change occurred, but the extent to which participants did what was asked of 
them. This is fundamentally important because inefficient regimen effect can be responsible for an 
ineffective intervention, and non-significant results.17 Rate of adherence to the use of activity 
monitoring devices as specified by the study protocol is a crucial parameter when evaluating 
programs. However, many studies often report outcomes rather than participant commitment to the 
intervention,18 leaving adherence under-reported or not reported at all.  
There is a rapidly increasing variety of commercial fitness trackers (e.g. the Fitbit™ range of 
wearable activity tracking devices) and associated smartphone applications widely used to support 
exercise goals. Their popularity within the general population suggests that they are likely to be 
perceived as acceptable to potential research participants. Unlike research-specific devices, such as 
the ActiGraph™ series of accelerometers that may be expensive and require specialized software to 
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analyze, these consumer devices are generally relatively inexpensive, unobtrusive to wear and require 
minimal interaction to share data.  This is particularly true if the functions are embedded in 
smartphone applications that enable multiple types of data recording on a single, commonly carried 
device.  
A high proportion of the population already carry smartphones and the rate of ownership in developed 
economies was estimated at above 70% in 2015.19 The use of such wearable PA monitors offers 
significant potential for researchers and clinicians working to promote or measure PA. Furthermore, 
validation studies of the accuracy of commercially available activity tracking technology have been 
undertaken.20-22 Functionality of such devices includes accelerometry, step counting (pedometers), 
visual feedback, activity progression, encouragement, social interaction and Global Positioning 
System (GPS) tracking, with some more sophisticated platforms incorporating more than one or all 
types of measurement.20  
Activity monitoring devices and applications have the potential to make a direct and real-time impact 
on self-management of PA and offer clinicians real world assessments of their patients’ daily activity 
patterns.21 Historically  the collection of an individual’s activity level data hasrelied on either direct 
observation or self-report (which can be cumbersome and potentially inaccurate), the latest generation 
of activity monitoring devices is frequently connected to a central internet platform for remote data 
sharing, thus enabling the collection of objective data. Although, limited data storage and 
transmission capabilities often means that participants are still self-reporting the readings from their 
devices. For research purposes we need to determine if the translation of these types of devices into 
reliable data collection tools, outside of a controlled environment, is acceptable to participants and 
will provide reliable and useful data. Irrespective of the type of device and how it is worn or carried, 
for valid and useful research data to be collected it must be operating and carried/worn by the 
participants for the expected duration of the study. 
User acceptance and perceived usefulness are known to be associated with a long-term adoption of 
health mobile applications,23 and studies assessing the effectiveness and feasibility of activity 
monitoring devices as a modality within a PA intervention have previously been undertaken. Such 
studies, however, have focused on chronic conditions (such as diabetes8 and COPD9), risk factors,10, 12,
15 specific device types,24 or specific populations (e.g., children/youth25, 26).  
A preliminary search of the Joanna Briggs Institute (JBI) Database of Systematic Reviews and 
Implementation Reports and the Cochrane Central Register of Controlled Trials found no systematic 
reviews focusing specifically on the adherence in the use of activity monitoring devices by adults with 
CVD. Therefore, this review has synthesized the current findings around adherence in the use of 
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activity devices or applications where study participants, with a confirmed diagnosis of CVD, have 
generated objective data measuring PA (not self-reported in a log or activity diary). In addition, the 
observed changes in PA and perceived acceptance of activity monitoring devices, intended to promote 
changes in PA, have been included.  
 
Objectives 
This review examines any adherence to the use of devices or applications used to improve PA in 
adults with CVD. Specifically, the objectives were to: 1. Quantify the extent of adherence (as 
specified by the study protocol) in the use of activity monitoring devices in the last five years; 2. 
Determine if the extent of adherence differs by gender, age, length of study, types of device and how 
the device was worn; 3. Determine if the wearing of an activity tracking device changes participants’ 
level of PA; and 4. Determine the perceived acceptability (satisfaction) of participants using an 
activity monitoring device or application to change levels of PA. This review provides an important 
resource to inform the development of future study protocols in this research area. 
 
  
5 
 
METHODS 
Protocol and registration 
This systematic review was undertaken using a protocol peer reviewed by JBI27 and registered with 
PROSPERO.28  
 
Eligibility criteria 
The inclusion criteria used were as follows: randomized control trials (RCTs) that compared an 
intervention for participants (aged 18 years and over) from any cardiovascular diagnostic group, who 
used an activity monitoring device in a research study within a community setting, to usual care.  
Eligibility included participants who have experienced one of the following cardiac events: Heart 
Failure (HF); cardiomyopathy conditions; medically managed acute myocardial infarction (STEMI-
elevation MI, non-STEMI elevation MI) – including or excluding post-MI revascularization; 
medically managed coronary artery disease (CAD) (e.g., stable angina); revascularization procedures 
including percutaneous coronary interventions and/or coronary artery bypass graft (CABG) surgery; 
post-insertion of implementable defibrillator and permanent pacemaker; repair and replacement of 
valve device(s); device implant for ventricular assist; and heart transplant. Studies assessing stroke, 
those including participants less than 18 years of age, or where devices required the physical 
transcription of data by a participant or researcher (e.g., writing down or entering the daily step 
count), were excluded.  
 
Usual care included promoting increases in PA to participants through printed material, verbal, and/or 
digital form (i.e. audio/video, CD-ROM, website, iPad or other tablet device, computer, basic step 
counter, computer/internet based program) and following normal daily PA behaviors and routines 
without directive to achieve increases in PA. Eligible studies did not include the use of a device or 
application that monitored activity as the comparator. Studies were included where they evaluated a 
device (worn or carried) or application to monitor PA (i.e. steps, distance travelled, GPS, time active, 
intensity, duration, rate, acceleration etc.) in a community context.  
 
Outcomes 
This review considered studies that described PA as an outcome measure, although not necessarily 
considered by the included study as one of the outcomes of the RCT and therefore not reported as 
such.  PA is usually defined in terms of intensity, duration, and rate of activity; 29 however, steps, 
floors climbed, and total distance travelled were also considered in this review.  Whilst rate of activity 
can be assessed in determinations of planned PA (e.g., fitness classes, or runs per week), in the current 
review overall PA accrued in daily living is considered. Perceived acceptability (participant’s 
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satisfaction) of using a PA device or application in interventions intended to promote increases in PA 
is also reported. 
 
Specifically, three outcomes were addressed: one primary and two secondary. The primary outcome 
was: adherence to the use of activity monitoring device to promote PA (adherence to the study 
protocol can be assessed by self-report, standardized or non-standardized instruments, reported as the 
feasibility of the intervention, evaluated from the extent of attrition or retention or documented as 
compliance). Secondary outcomes included: effect of device on PA levels (measured as duration, rate 
and intensity of PA, steps, floors climbed, distance travelled), and perceived acceptability 
(satisfaction) of using an activity monitoring device or application. 
 
Information sources  
The search strategy was designed to find both published and unpublished articles in the English 
language only. This was due to limited access to translators and budgetary constraints. Papers 
published from June 2012 to October 2017 were included representing a period of increasing 
availability and acceptance of activity tracking devices in the general population and their 
incorporation into research protocols.  
 
Search 
An electronic search was designed and performed by an experienced research librarian (PN) on 6 
October 2017 using the following databases: Medline; CINAHL; PsycINFO; Scopus; Web of 
Science; Cochrane Central Register of Controlled Trials; ANZ Clinical Trials Registry; 
Clinicaltrials.gov; and WHO International Clinical Trial Registry Platform. It is noted that Embase 
has not been included in the search strategy as this database is unavailable at Flinders University. The 
reference list of all studies selected were screened for additional studies not already included in the 
search to inform the findings, and in the case of missing or incomplete data, corresponding authors 
were contacted. A copy of the detailed search strategy can be found in Appendix I.  
 
Study selection 
Following the search, all citations were collated and uploaded into Endnote and duplicates removed. 
Titles and abstracts were screened by two independent reviewers (TM and CK) for assessment against 
the inclusion criteria. If consensus could not be reached a third reviewer (RC) would assess.  Full text 
articles were retrieved for those studies meeting the inclusion criteria, or to determine eligibility if the 
title and abstract did not provide enough information. The details of the selected studies were 
imported into JBI SUMARI30 and comprehensively assessed against inclusion criteria (TM and CK). 
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If consensus could not be reached the third reviewer (RC) would assess. Full text studies that did not 
meet these criteria were excluded and reasons entered into the PRISMA flow diagram ( Figure 1).  
 
Study protocol definitions 
Tracking Devices 
A recent review by Ridgers and colleagues25 identified the key elements of an activity tracking device 
as being electronic, wearable, using sensors to track the user’s movements and having the ability to 
provide feedback beyond a basic display. Building upon this, an activity monitoring device in this 
review is defined as a wearable electronic device or smartphone application which records some 
aspect of movement or location for which the data can be downloaded and analyzed.  
Adherence 
Adherence is defined as “the extent to which a person’s behavior (taking medication, following a diet 
or exercise plan, and/or executing lifestyle change) corresponds with the recommendations from a 
health care professional”.31, p.3 Therefore, the measurement of adherence largely depends upon the 
nature of the study protocol and the recommendations provided. In this context there are no 
restrictions on how adherence is measured. The current review included studies where adherence to a 
device was assessed by self-report, standardized or non-standardized instruments, reported as the 
feasibility of the intervention, evaluated from the rate of attrition or retention or documented as 
compliance.    
Physical Activity Interventions  
Interventions promoting improvements in PA in daily living that used a PA device or application, for 
example, where participants are asked to use and manage an activity monitoring device or application 
and provide these data (as were determined by the study protocol) to the study were included.  
Devices which required the physical transcription of data by a participant or researcher (e.g. writing 
down or entering the daily step count) were excluded.  
 
Data collection process  
Study characteristics and outcome data were systematically extracted by one reviewer (TM) and 
thoroughly checked for accuracy and completeness by a second independent reviewer (CK). Contact 
was made with corresponding authors to determine the inclusion of eight studies as some required 
information was unavailable in the manuscripts. This resulted in an additional three studies being 
excluded from the review (see Appendix II for full list of excluded studies). 
 
Data items 
Data items extracted were: characteristics of eligible studies (author and data of publication, setting 
and country, sample size, study population (mean age and gender of the participants), intervention 
group (IG) description, type of device and where worn, and duration of the follow-up period); and 
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data relating to primary and secondary outcomes (summary of outcome measure and results).  The 
outcomes previously described were considered to assess inclusion. Overall means and standard 
deviations (SDs) of age and proportion of gender for all participants at the point of randomization are 
reported. Where demographic data were not available individually by IG and control group (CG) 
numbers are provided as overall only. Where intention-to-treat analyses were not undertaken, and 
some loss to follow up was experienced, results in the primary outcome table are adjusted to include 
all randomized participants, to assess actual, rather than adherence rates after attrition. 
 
Risk of bias in individual studies 
Within study critical appraisal was performed for all included articles at the study level using the JBI 
standardized critical appraisal instrument for RCTs.32 To minimize the risk of bias, methodological 
quality was assessed by two independent reviewers (TM and CK) and disagreement was resolved by 
discussion or referral to a third reviewer (RAC). This information was used in assessing the strength 
of the body of evidence being reviewed. 
 
Summary measures 
Summary measures used to address the primary and secondary outcomes were: percentages to 
determine rate of adherence, mean number of steps per day, mean energy expended and mean number 
of minutes spend doing PA to assess changes in PA using objective data, and percentages of user 
acceptability.  
 
Synthesis of results:  
As insufficient studies were identified that addressed the same, or similar, research question, a meta-
analysis was not performed. A narrative synthesis of the study characteristics, methodological quality, 
summary of outcome measures, and statistical significance is provided.  
 
Risk of bias across studies:  
A summary of findings providing an assessment of risk of bias across studies was undertaken using 
GRADEPro GDT software. The GRADE approach for grading the quality of evidence was followed 
presenting a narrative synthesis of the evidence based on study limitations (risk of bias) including, 
indirectness, inconsistency, imprecision, and publication bias.  
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RESULTS 
Study selection 
The electronic search identified 1,653 records and an additional 14 were identified from clinical trials 
registries. Following de-duplication, the title and abstract of 1,667 citations were screened and 74 
papers were selected for full title and abstract assessment. Sixty-four papers were excluded of which 
46 did not meet our selection criteria, 14 were incomplete studies (abstracts or protocols), and two 
were duplicates of previous publications. An additional two studies were excluded as we were unable 
to contact the authors. Ten studies were identified for inclusion in this review – the first being 
published in 2012.  
 
Study characteristics 
The ten RCTs included were conducted in nine developed countries; Australia,33 Belgium,34 Canada,35 
France,36 Germany,37 Norway,38 Portugal,39 the United Kingdom,40 and the United States of America 
(Table 1).41, 42 Studies included a total of 849 (27.7% female) participants ranging in age from 42 to 
82 years (mean age range 54 to 70.2 years), who had been previously diagnosed with an eligible 
cardiac event. The study populations included those with ACS,33-36, 39-41 HF,34, 36, 42 and CHD.36, 37 All 
RCTs included the wearing or carrying of a device that objectively measured PA; ten using an 
accelerometer and two a pedometer. Follow up times ranged from one to 12 months.  
 
Risk of bias within studies 
All ten studies included had important methodological weaknesses. Randomization was adequately 
concealed in only five studies,33, 35, 39, 40, 42  blinding of the outcome assessors was found for four,34, 37, 
38, 42 intention to treat analysis was undertaken in only three,35, 36, 38 and participant blinding was not 
used in the any of the RCTs. Overall, only two studies35, 38 reached a quality score greater than 65% 
(Table 2).  
 
Results of individual studies 
Six studies33, 36, 37, 39, 40, 42 addressed our primary outcome (adherence) and involved 556 participants 
(33.1% female). Mean adherence for these six RCTs was 59.1% at last follow up time; ranging from 
39.6% to 85.7% at 6 months. In three of the studies33, 40, 42 adherence rates were presented for two time 
points – first and second follow-up; however, in all six, final follow-up was at six months. Two 
studies33, 42 reported the rate of adherence as decreasing with time (76.4% and 39.0% to 58.3% and 
27.0% respectively) and in the other40 the adherence rate remained constant (39.6%); however, these 
data should be interpreted with caution due to the methodological limitations of studies. 
 
10 
 
Where devices were worn/carried by both IG and CG and PA data were collected objectively, IG 
participants showed a greater adherence in four of the studies.33, 37, 39, 42 Varnfield and colleagues33 
found a significant difference in adherence rates between IG and CG (p<0.05) concluding that the use 
of a smartphone as part of their care assessment platform (IG) was more effective in keeping 
participants in rehabilitation (80% compared to 47% in the CG), and as effective in improving health 
outcomes.33 
 
Table 4 shows the studies that addressed our secondary outcomes; objective measurement of PA, and 
user acceptability to the device. There were nine RCTs involving 798 participants (27.6% female), 
that collected objectively measured PA. The majority of these RCTs33-35, 37, 40-42 used steps per day 
from baseline to follow up as an outcome measure. Change in steps per day was significantly different 
(p<0.05) between IG and CG in four of these studies,35, 37, 40, 43 two reported non-significant results,34, 
42, and in one study33 significance was not reported. The one study reporting changes in steps using a 
pedometer reported an increase of 1,973.9 steps per day as compared to the RCTs reporting PA using 
accelerometers where steps per day increased from 49740 to 1,58637 in the IGs. Two studies36, 39 
reported PA as energy expended at different intensity levels and again significant differences between 
IG and CG were reported.   
 
There were two studies33, 34 addressing this review’s last outcome involving 259 participants (15.1% 
female). Both reported very high acceptability to using a device (97% and 85% respectively). In 2015, 
Frederix and co-authors34 reported a 95% acceptance to their tele-rehabilitation program with 44% 
saying they were very satisfied and 51% satisfied. More recently, Varnfield and colleagues33 used an 
accelerometer in a smartphone purely as a motivational tool and reported that 85% of participants 
found the step counter to be motivational in reaching their CR goalsteam.33 
 
Risk of bias across studies 
The certainty of evidence for the three outcomes was Generated using GRADEPro GDT software 
(Table 5). Certainty was moderate for the primary (adherence) and first secondary outcome (PA 
levels), due to methodological heterogeneity of studies and no intention-to-treat analysis which may 
have impacted the adherence to the device and the mean number of steps/level of PA reported. 
Evidence for the acceptability  outcome was provided by qualitative self-report feedback and the 
certainty of evidence has been downgraded to very low accordingly. 
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DISCUSSION 
Summary of evidence 
No reviews have previously examined adherence to the use of activity monitoring devices amongst 
participants with a confirmed diagnosis of CVD. This systematic review has examined the extent of 
adherence to any activity monitoring device used to collect objective PA data between 2012 to 2017. 
Of the 1,667 citations reviewed, ten RCTs were eligible for inclusion suggesting that this area has not 
been well researched. Six studies addressed the primary outcome (adherence) involving 556 
participants (33.1% female). Overall, adherence across these six studies was 59.1% at last follow up 
time; ranging from 39.6% to 85.7% at six months. 
 
The primary outcome for this review is adherence to a device used to objectively measure PA, distinct 
from PA assessed by self-report.44 However, the inclusion criteria allowed studies that included the 
objective measurement of PA and also examined adherence to the study protocol assessed by self-
report, standardized or non-standardized instruments, reported as the feasibility of the intervention, 
evaluated from the extent of attrition (i.e. abandonment of wearing the tracking device) or retention, 
or documented as compliance. In two studies,33, 40 adherence was defined only as adherence to the 
protocol. In these studies, it was not possible to ascertain whether the non-adherers, although not 
completing, or adhering to, the protocol, had indeed adhered to using the device. A systematic review, 
conducted to establish measures available to assess self-reported adherence to home-based 
rehabilitation programs, found a gap in the literature for well-developed measures available to capture 
adherence.17 Rather than simply record numbers of those attending/not attending, or completing an 
intervention, it is suggested that a well validated and reliable self-report measure may provide extra 
support to clinicians in determining whether their prescribed exercise regime if effective, needs 
adjusting or if the patient needs further support. In the paper by Varnfield and colleagues,33, p.1774 a 
significant difference (p<0.05) in adherence to their CR program, between IG and CG, is reported as 
mainly attributed to “dislike of group based classes, lack of personalized exercise programs, return to 
work demands, family commitments and poor motivation” concluding that the use of a smartphone in 
conjunction with a home based cardiac rehabilitation program overcame some of these key barriers. 
 
A systematic review conducted by Bravata and colleagues,45 regarding the use of pedometers to 
increase PA, found that across 26 studies (8 randomized controlled trials and 18 observational 
studies), having a step goal was an important predictor of increased PA. Lau and colleagues46 found 
consistent evidence supporting the improvement of psychosocial variables (e.g., self-efficacy47) 
through information and communications technology (ICT) interventions; however, the evidence for 
the change in behavioral variables, such as PA level, was less consistent. Barriers are likely to exist 
and differ at each of the levels of behavior change.48 According to a study investigating the use of 
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activity monitoring devices for the self-management of chronic conditions,49 there are three key 
critical components to the long-term adherence to activity monitoring devices: formation of habit; 
social motivation; and goal reinforcement feedback. Additionally, usability is named as a key factor in 
the meaningful use of activity monitoring devices. As Goldberg and colleagues50, p.s194 purport, 
“functionality is for naught if not used effectively, efficiently, and safely by its human users.”  
 
Guiraud and co-authors36 analyzed a group of participants who had previously been non-compliant to 
PA and participation in a CR program. They were subsequently randomized into activity monitoring 
device and non-device wearing groups to assess adherence to the device. This evaluation is important 
in that it provides evidence for those who may be able to adhere to a program of exercise or protocol; 
however, who are unable to adhere to the use of an activity monitoring device, and vice versa. In other 
settings, studies have shown that using pedometers to observe levels of can be useful to indicate 
adherence to activity programs.51 Further research is needed to uncover whether adherence to a 
protocol may be a confounder in assessing adherence to the device. 
 
While pedometers are becoming an item of everyday wear in the general population,52 the use of 
accelerometers for research purposes has also seen a dramatic increase in use more recently53, 54 and 
due to their size, ease of use, and non-invasiveness, they are commonly used to as an objective 
method for assessing PA in field-based research.44 Compared to pedometers, accelerometers provide 
an increase in the accuracy of data,55 are superior to self-report,56 and have the ability to integrate 
prompts and cues, reward mechanisms and self-monitoring of behavioral outcomes.57 In this current 
review, two studies reported on pedometer use and eight on accelerometers. The following devices 
were identified: Accelerometers (ActiGraph,39, 42 Aipermon 440,37 Sensewear Pro3,38, 40 tri axial 
Yorbody,34 and single axis Accelerometer36); and the Yamax Digiwalker35 and tri-axis technology 
(3D)41 pedometers; although, Anderson41 describes his pedometers as having tri-axis technology and 
measuring vertical acceleration, indicating technology closer to an accelerometer. One study used 
systems integrated with online platforms and a tablet device and but did not state the brand of 
accelerometer.42  
 
A recent review on the use of wearable devices to promote PA15 warns that there have been few 
studies evaluating their efficacy in promoting PA and research is needed to determine effectiveness, 
especially in marginalized communities, and with children and adolescents. It was not possible to 
ascertain any meaningful differences between countries, communities or settings in this review due to 
the small number of studies conducted in developed countries all with similar health practices and 
technologies. Furthermore, there is no representation in this review from developing countries or 
marginalized populations. Participants in the RCTs eligible for this review ranged in age from 42 to 
82 years. Lau and colleagues46 also concluded that very few systematic reviews have documented the 
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effects of ICT-based interventions on PA behavior in children and adolescents specifically. In one of 
the few studies found to include participants aged less than 40 years58 a marked attrition to wearing an 
activity tracker for six weeks was shown in a small study of undergraduate students aged 20 to 24 
years. Attrition at two weeks was 50%, 75% at four weeks, and only three participants were reported 
adhering for the full six weeks (11.5%). A variety of reasons for non-adherence were reported ranging 
from ‘the device was uncomfortable to wear’ to ‘I forgot to put it on in the morning’ although the 
authors noted, that although participants seemed to object to carrying the activity trackers, most had 
no trouble in remembering to carry their keys, wallets, and mobile phones. One participant in the 
study complained that “physical activity trackers should be inconspicuous” while another remarked 
on the frustration in having “to remember to take it out of my pocket and put it on the new clothes I 
am wearing” when changing her clothes or taking a shower.58, p.7 The low mean adherence rate 
(59.1%) identified may be a consequence of the age of the participants and raises the question of what 
technology is more suitable for this age group, and the possibility that accelerometry more suited to a 
young demographic. In addition to the lack of younger participants found in this review, from 849 
participants only 28.6% (n=243) were female. It is known that women are under-represented in 
cardiac care4 despite men and women experiencing the same rates of CVD.2 Gender differences in the 
adoption of PA trackers have been understudied and are rarely reported,58 and this review has found a 
lack of empirical research in this area. Research is warranted to understand the gender differences in 
this area.59  
 
The effectiveness and validity of using activity monitoring devices to record and collect subjective PA 
data has been shown,45 however, now emerging are ethical considerations around the use of 
accelerometry. To stimulate discussion in the literature, Fuller, Shareck and Stanley60 propose four 
areas needing to be addressed: informed consent; privacy and confidentiality; mitigation of risk; and 
the additional considerations of marginalized (vulnerable) populations. One example of this is the 
volume of data that are produced from an accelerometer. Data may give a detailed account of a 
participant’s movements and activities during a set period, much of which may not be relevant to the 
research and so not easily described in the protocol, or adequately represented in a consent form. 
Alternatively, giving the participant the ability to pause or delete data which they may deem private, 
may impact negatively on the research intent.60  
 
Limitations 
As with any systematic review, its strength depends on the data reported in the individual studies that 
meet the criteria and report on the outcomes. This review included ten eligible studies each with 
notable methodological weaknesses. Randomization was adequately concerned in only five studies, 
intention to treat analysis was undertaken in only three, and assessment of outcome was blinded in 
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six. Data should therefore be interpreted with care. In addition, there was a high heterogeneity 
between studies and for each of the variables addressed in our second objective. Therefore, the 
authors were unable to undertake an overall meta-analysis, or sub-analyses to provide evidence for 
our second objective: to determine if the extent of adherence differs by gender, age, length of study, 
types of device and how the device was worn. 
 
CONCLUSIONS 
This review highlights the lack of evidence for the adherence to the use of activity monitoring 
devices. Review outcomes suggest that the evidence is not equally presented by age and gender, nor 
does it address the specific needs of using this technology in marginalized communities. As research 
addressing the use of activity monitoring devices evolves and the objectively collected physical 
activity data is further validated, challenges remain to ascertain the effectiveness of using activity 
monitoring devices as we move from subjective (self-report) to objective data. In addition, there are 
ethical issues that will need to be addressed surrounding consent to, and risk from, using such devices 
and consideration of privacy, confidentiality and clinical outcomes.  
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Table 1: Characteristics of included studies 
Study Country (setting) Participants 
Age in years 
mean (SD) [range] 
Female  
n (%) 
CVD 
diagnosis Device (worn) Intervention 
Follow-up  
(length of study) 
Anderson, 
Harris et al. 
201543 
 
US 
N=38 
 
IG: n=18  
CG: n=20 
(usual care) 
57.0 (10.8) 
[46.2 – 67.8]    
 
IG: 56.6 (10.6) 
CG: 59.4 (12.9) 
IG: 3 (17) 
CG: 8 (40) 
CAD 
(PCTA, 
stent, 
CABG, MI, 
angina) 
Pedometer 
(unknown) 
Pedometer worn 3 months to measure 
steps/day (during waking hours). Mailed 
back in reply-paid envelope 
3 months 
Christle, 
Schlumberger 
et al. 201737 Germany  
N=70 
 
IG: n=35 
CG: n=35 
(usual care) 
70.0 (SD 9.0) 
[61 – 79] 
 
IG: 70.0 (8.0) 
CG: 70.0 (9.0) 
28 (39) 
 
IG: 14 (39) 
CG: 14 (39) 
CD (AHA - 
Class C 
mod/high) 
Accelerometer 
(hip) 
Once-weekly individualized combined 
exercise (10 days)  
6 months 
Devi, Powell 
et al. 201440 
UK; GPs  
N=94 
 
IG: n=48 
CG: n=46 
(usual care) 
[56.1 – 76.3] 
 
IG: 66.3 (8.3) 
CG: 66.2 (10.1) 
IG: 14 (29) 
CG: 10 (22) CHD  
Accelerometer 
(R upper arm) 
Web-based cardiac rehabilitation program 
“ActivateYourHeart” delivered via the 
internet (no face to face) – accelerometer 
worn 2 weekdays (12 hours/day) 
1 & 6 months 
Frederix, 
Hansen et al 
201534 Belgium 
N=139 
 
IG: n=69 
CG: n=70 
(usual care) 
61.0 (9.0) 
[52 – 70] 
 
IG: 61.0 (9.0) 
CG: 61.8 (8.0) 
25 (18) 
 
IG: 10 (14) 
CG: 15 (21) 
CAD or 
CHF 
Accelerometer 
(pocket) 
6-week web-based, comprehensive tele-CR 
(from weeks 6 to 12 of CR) plus usual 12-
week center-based CR 
1½ & 6 months 
Guiraud, 
Granger et al. 
201236 France; CRP at clinic 
N=29 
 
IG: n=19 
CG: n=10 
(usual care) 
57.4 (12.4) 
[41.9 – 73.6] 
 
IG: 54.5 (12.6) 
CG: 62.9 (10.7) 
5 (17) 
 
IG: 2 (11) 
CG: 3 (30) 
CAD, HF Accelerometer (waistband) 
Wore accelerometer for 8 weeks; telephone 
feedback and support (data automatically 
uploaded to web portal) 
2 months 
Houle, Doyon 
et al. 201235 
Canada 
N=65 
 
IG: n=32 
CG: n=33 
(usual care) 
[50 – 68] 
 
IG: 58.0 (8.0) 
CG: 59.0 (9.0) 
14 (21.5) 
 
IG: 6 (19) 
CG: 8 (25) 
ACS 
(unstable 
angina, 
STEMI or 
non-STEMI) 
Pedometer 
(hip) 
Pedometer-based program, PA behavior 
(average steps/day) associated with a diary 
to record other PA besides walking 
3, 6, 9, & 12 
months  
Malmo et al. 
(2014)61 Norway 
N=51 
 
IG: n=26 
CG: n=25 
[48 – 71] 
 
IG: 56.0 (8.0) 
CG: 62.0 (9.0) 
IG: 6 (23) 
CG: 3 (22) 
AF  
(non-
permanent) 
Accelerometer 
(upper arm) 
Device (SenseWear Pro 3) was worn for at 
least 4 consecutive days both during the 4-
week baseline period and the two last weeks 
of the intervention period  
1 and 5 months 
2 
 
 
  
(habitual 
PA) 
Ribeiro, 
Oliveira et al. 
201739 
Portugal 
(Outpatient 
clinic) 
N=138 
 
IG: n=71 
CG: n=67 
(usual care) 
[45 – 67] 
 
IG: 54.0 (9.0) 
CG: 58.0 (9.0) 
IG: 23 (92) 
CG: 20 (80) MI  
Accelerometer 
(right hip)  
8-week aerobic exercise program plus usual 
medical care and follow-up.  Filtered 
digitized acceleration signals were recorded 
by accelerometers  
2 months 
Varnfield, 
Karunanithi et 
al. 201433  
 
Australia 
N= 120 
 
IG: n=60 
CG: n=60 
(usual care) 
[46.1 – 66.3] 
 
IG:  55.7 (10.4) 
CG: 55.5 (9.6) 
14 (12) 
 
IG: 9 (15) 
CG: 5 (8) 
MI Accelerometer (smartphone) 
Two supervised exercise and 1 hour of 
educational sessions on a weekly basis for 6 
weeks at one of four Health Service District 
community centres. Smartphone (Nokia 
N96, Nokia Inc preinstalled with health 
diary (Wellness Diary, Nokia Research) and 
activity monitoring (StepCounter, Nokia 
Research) used for health and exercise 
monitoring, and delivery of motivational 
and educational materials to participants. 
6 months  
Young, 
Hertzog et al. 
201642 
US, 
Nebraska 
N=105 
 
IG: n=54 
CG: n=51 
(usual care) 
70.2 (12.2) 
[58.0 – 82.4] 
 
IG: 68.7 (11.8) 
CG: 71.8 (12.6) 
70 (67) 
 
IG: 29 (53) 
CG: 38 (75) 
 
HF  
(Class II-IV) 
Accelerometer 
(waist) 
Usual care plus 12 week (PATCH) self-
management (SM) training and coaching 
program delivered by telephone plus in two phases: a one-on-one in-hospital SM training session and post discharge reinforcement sessions (twice a week for weeks 1–2, once a week for weeks 3–6, & every other week for weeks 7–12) delivered by telephone.  
1, 3 & 6 months 
Notes: *no significant baseline differences between groups; ACS: acute coronary syndrome; AHA: American Heart Association; CABG: coronary artery bypass graft; CG: Control group; CD: cardiac disease; 
CR: cardiac rehabilitation; CRP; cardiac rehabilitation maintenance program; IG: Intervention group; PA: Physical Activity; PCI: percutaneous coronary intervention; PHC: Primary Healthcare; STEMI: ST-
elevation myocardial infarction; UK: United Kingdom; US: United States; ↓lower/decrease; ↑higher/increase 
3 
 
Table 2: Risk of bias within studies 
 Anderson 
et al. 
2015 
Christle 
et al. 
2017 
Devi et 
al. 
2014 
Frederix 
et al 
2015 
Guiraud 
et al. 
2012 
Houle 
et al. 
2012 
Malmo 
et al. 
2014 
Ribeiro 
et al. 
2017 
Varnfield 
et al. 
2014 
Young 
et al. 
2016 
Overall 
 
JBI RCT critical appraisal tool n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) 
1. Was true randomization used for assignment 
of participants to treatment groups? U Y Y Y
a U Ya Ya Y Y Y 8 (80.0) 
2. Was allocation to treatment groups 
concealed? U N Y N U Y
a N Y Y Y 5 (50.0) 
3. Were treatment groups similar at baseline? Y Y Y Y Y Y Y Y Y N 9 (90.0) 
4. Were participants blind to treatment 
assignment? U N
a N N U Na N N N N 0 (0.0) 
5. Were those delivering treatment blind to 
treatment assignment? N Y N N U N N N N N 1 (10.0) 
6. Were outcome assessors blind to treatment 
assignment? N Y N Y
a U N Ya N N Y 4 (40.0) 
7. Were treatments groups treated identically 
other than the intervention of interest? Y Y Y Y Y Y Y Y Y Y 10 (100.0) 
8. Was follow up complete and if not, were 
differences between groups in terms of their 
follow up adequately described and 
analyzed? 
Y N Y Y Y N Y Y N Y 7 (70.0) 
9. Were participants analyzed in the groups to 
which they were randomized? N N N N Y Y Y N N N 3 (30.0) 
10. Were outcomes measured in the same way 
for treatment groups Y Y Y Y Y Y Y Y N Y 9 (90.0) 
11. Were outcomes measured in a reliable way? N Y Y Y Y Y Y Y Y Y 9 (90.0) 
12. Was appropriate statistical analysis used? N N N N N Y Y N N N 2 (20.0) 
13. Was the trial design appropriate, and any 
deviations from the standard RCT design 
(individual randomization, parallel groups) 
accounted for in the conduct and analysis of 
the trial? 
Y Y Y Y Y Y Y Y N Y 9 (90.0) 
 5 (38.5) 8 (61.5) 8 (61.5) 8 (61.5) 7 (53.8) 9 (69.2) 10 (76.9) 8 (61.5) 5 (38.5) 8 (61.5)  
a Information obtained from primary research author; U Unable to contact author on this matter 
Table 3: Summary of primary outcome: Adherence to using the device 
Study Adherence to device: Results (n=number of participants analyzed) Adherence 
rate at follow-
up (%)  
Guiraud et 
al. 201236 
Accelerometer procedure 
and use of web portal 
• Overall 
o 100% adherence to device for both IG and CG at 
2 months 
• CG 
o 36.8% of the IG achieved target for moderate-
intensity PA  at 2 months 
 
100.0 
 
Christle et 
al. 201737 
Wore accelerometer on hip 
for 10 days (min 10hrs/day)  
• IG (n=30) 
o 84% adherence at 6 months 
• CG (n=30) 
o 77% adherence  at 6 months 
• Non-completion: 
 n=1 (IG) developed muscle pain resulting in a 
discontinuation of exercise 
 n=7 (2 IG, 5 CG) discontinued due to reasons 
unrelated to clinical status or the intervention 
 n=2 (IG) were not included in the analyses due 
to incomplete data 
85.7 
 
 
Varnfield 
et al. 
201433 
Used accelerometer 
(smartphone) to record ≥ 30 
minutes of moderate activity 
on most days of the week 
 
• IG ( n=26) 
o ↑ than CG - adherence to program (94%)* at 4 
weeks 
o ↑ than CG - completion of program (80%)* at 6 
months 
o Non-completion: 
 logistical (2%); change in health (9%); 
difficultly in using IT tools (7%); lack of 
motivation (2%); improved health (2%) and 
other (5%) 
• CG ( n=46) 
o ↓ than IG - adherence to program (68%)* at 4 
weeks 
o ↓ than IG - completion of program (46%)* at 6 
months 
o Non-completion (>70%): 
 logistical (25%); completing life demands 
(14%); change in health (14%); change in 
criteria (2%); study design (10%); lack of 
motivation (4%); privacy (2%); and other (2%) 
58.3 
Ribeiro et 
al. 201739 
Wore accelerometer 7 
consecutive days; measured 
PA ≥ 8 hours/day 
 
• IG (n=71) 
o 45.1% (32) at 8 weeks 
o Non-completion: 
 2.8% (2) not adhere to protocol (<80% exercise 
sessions) 
 54.9 (39) no 7-day and/or 8hr/day PA record 
• CG (n=67) 
o 43.3% (29) at 8 weeks 
o Non-completion: 
 6.0% (4) lost to follow up 
 56.7% (38) no 7-day and/or 8hr/day PA record 
44.2 
Devi et al. 
201440 
Wore accelerometer 2 
weekdays (12 hours/day) – 
IG only 
 
 
 
• IG (n=48) 
o 39.6% (19) completed the intervention (6 
months) 
o 60.4% (29) did not progress past stage 3 (1 
month) 
39.6 
2 
 
 
  
o average 3 log-ins/week/participant – over 
program mean=18.68 (SD 13.13, range 1-51) 
Young et 
al. 201642 
Wore accelerometer on waist daily  • IG ( n=51) o 45.1% (23) reported 7 days/week at 3 months 
o 54.9% (28) reported 0-6 days/week exercise at 3 
months 
o 38.0% (19) reported 7 days/week at 6 months 
o 62.0% (31) reported 0-6 days/week exercise at 6 
months 
• CG ( n=49) 
o 34.0% (16) reported 7 days/week at 3 months 
o 66.0% (31) reported 0-6 days/week exercise at 3 
months 
o 17.4% (8) reported 7 days/week at 6 months 
o 82.6% (38) reported 0-6 days/week exercise at 6 
months 
27.0 
Notes: CAP: care assessment platform; CG: control group; CI: confidence interval; CMP: cardiac rehabilitation maintenance 
program; CR: cardiac rehabilitation; IG: Intervention group; IT: information technology; PA: physical activity; RR: relative risk; 
SD: standard deviation; ↓lower/decrease; ↑higher/increase; * p<0.05 
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Table 4: Summary of secondary outcomes: Effectiveness and Satisfaction 
 
 
Study Objective PA measured by accelerometer Result  p value 
Christle, 
Schlumberger 
et al. 201737 
Change in steps/day from baseline • IG ↑ steps / day (+1586) at 6 months 
• CG ↓ steps / day (-838) at 6 months <0.01 
Devi, Powell 
et al. 201440 Change in steps/day from baseline 
• IG ↑ steps/day (+497) at 6 weeks 
• CG ↓ steps/day (-861) at 6 weeks <0.02 
Frederix, 
Hansen et al 
201534 
Change in steps/day from baseline 
• IG ↑ steps/day (+351) at 6 weeks 
• IG ↑ steps/day (+785) at 6 months 
• CG ↑ steps /day at 6 months 
ns 
Young, 
Hertzog et al. 
201642 Change in steps/day from baseline 
• IG 
o ↑ steps/day at 3 and 6 months  
o ↑ Kcal/kg/day at 3 and 6 months  
o ↑ daily minutes of moderate/vigorous 
activity at 3 and 6 months  
ns 
Guiraud, 
Granger et al. 
201236 
Energy expended, time doing 
moderate intensity PA 
 
PA and time spent at different 
intensity levels (mean minutes)  
• IG 
o ↑ total energy expended at 2 months 
o ↑ energy expended at moderate 
intensity at 2 months  
o ↑ time spent at moderate intensity 
PA at 2 months 
0.004 
0.013 
0.002 
Ribeiro, 
Oliveira et al. 
201739 Minutes PA/day: sedentary PA; light PA; moderate-to-vigorous 
PA; total PA (counts/minute)  
• IG 
o ↑ moderate-to-vigorous PA 
(mins/day) at 2 months 
• CG 
o unchanged moderate-to-vigorous PA 
(mins/day) at 2 months 
 
0.030 
 
0.024 
Varnfield, 
Karunanithi et 
al. 201433 
Step number, duration and 
intensity  
• IG 
o ↑ in walking speed at 1.5 months 
o ↑ steps per day at 1.5 months 
NR 
Study Objective PA measured by pedometer   
Anderson, 
Harris et al. 
201543 
Change in steps/day from baseline 
• IG ↑ steps/day (+1973.9) at 3 months  
• CG ↓ steps per day (-1369) at 3 
months 
0.010 
Houle, Doyon 
et al. 201235 
> 7500 steps/day at each time 
point 
• IG 
o ↑ % at 6, 9, and 12 months (p=0.01; 
0.03; 0.04) 
• Interaction effect (group by time) in 
PA level was different between groups 
from baseline to 6-month follow-up 
(p=0.033) 
 
0.033 
Study User acceptability  Result 
Frederix, 
Hansen et al. 
201534 
Qualitative - offline feedback 
forms 
• 97% acceptability in using motion sensor (easy to read 
and easy to use) 
• 95% (65/69) acceptability in tele rehabilitation 
program: very satisfied (44%, 30/69); satisfied (51%, 
35/69). 
Varnfield et 
al. 201433 
Acceptability to step counter • >85% found step counter to be motivational in 
reaching CR goals 
Notes: CG: control group; GPS: Global Positioning System; IG: Intervention group; ↓lower/decrease; ↑higher/increase; 
NR: not reported; ns: non-significant; PA: physical activity 
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Table 5: GRADE SUMMARY OF FINDINGS 
Extent of adherence to the use of an activity monitoring device to collect objective physical 
activity data; including effect of device on PA and acceptance of device 
Patient or population: Adults (aged 18 years and over) with CVD  
Setting: Community 
Intervention: Use of an activity monitoring device to collect objective physical activity data  
Comparison: Usual care  
Outcomes Impact № of 
participants  
(studies) 
Certainty of the 
evidence 
(GRADE)  
P1:  Rate of adherence to activity monitoring 
device to promote PA assessed with:  
rate of adherence (percentage). 
Follow up: mean 6 months. 
Mean adherence 59.1% (range 39.6-85.7). 
There was heterogeneity of setting, 
intervention, type of device, where device worn 
and means of collection of data across six 
studies.  
493 
(6 RCTs) 
⨁⨁⨁◯ 
MODERATE a 
S1: Effect of device on PA levels  
assessed with: steps per day/level of 
activity/energy expended. 
Follow up: mean 6 months.  
Increase in steps/day was significantly different 
between intervention and controls (p<0.05) in 
the 4 of 6 studies where this was reported. One 
study did not report significance and the last 
two studies reported a significant difference in 
energy expended/time spent doing PA. 
798 
(9 RCTs) 
⨁⨁⨁◯ 
MODERATE b 
S2: Perceived acceptability (satisfaction) of 
using an activity monitoring device or 
application to promote increases in PA 
assessed with: qualitative feedback  
Follow up: mean 6 months.  
Two studies reported the participant’s 
acceptability and satisfaction towards the 
device. These data were self-report collected 
using feedback forms. Acceptability to device 
was reported for more than 85% of 
participants. 
259 
(2 RCTs) 
⨁◯◯◯ 
VERY LOW a, c 
GRADE Working Group grades of evidence 
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect 
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but 
there is a possibility that it is substantially different 
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect 
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the 
estimate of effect  
Explanations 
a. Methodological heterogeneity of studies  
b. No intention-to-treat analysis may have impacted on mean number of steps/level of PA reported  
c. These data are qualitative collected from feedback forms.  
 
 
 
 
 
 
APPENDIX I– SEARCH STRATEGY APPLIED ACROSS DATABASES 
Ovid MEDLINE(R) Epub Ahead of Print, In-Process & Other Non-Indexed Citations, Ovid 
MEDLINE(R) Daily, Ovid MEDLINE and Versions(R) 
# Searches 
1 cardiovascular diseases/   
2 exp heart diseases/   
3 exp Coronary Artery Bypass/   
4 exp Myocardial Revascularization/   
5 exp heart transplantation/   
6 Percutaneous Coronary Intervention/ or Angioplasty, Balloon, Coronary/   
7 Heart Valve Prosthesis/   
8 Pulmonary embolism/   
9 ((myocardial or cardiac or heart) adj2 (infarct* or isch?emi*)).tw.   
10 (coronary adj2 (syndrome* or disease* or event* or occlusion* or stenos* or thrombo*)).tw.   
11 (myocard* adj2 revasculari?ation).tw.   
12 (STEMI or NSTEMI).tw.   
13 (ST adj2 (elevat* or depress*)).tw.   
14 "heart transplant*".tw.   
15 angina.tw.   
16 (heart adj2 (failure or attack or bypass or disease*)).tw.   
17 ((heart or cardiac or myocard*) adj2 (fail* or insufficien* or decomp*)).tw.   
18 (HFpEF or HFrEF or left ventricular ejection fraction or ((preserved or reduced) adj ejection fraction)).tw.  
 
19 (LV dysfunction or (diastolic adj (dysfunction* or failure*)) or (systolic adj (dysfunction* or failure*))).tw.  
 
20 pulmonary embolism*.tw.   
21 CABG.tw.   
22 (coronary adj2 bypass).tw.   
23 PTCA.tw.   
24 angioplast*.tw.   
25 PCI.tw.   
26 (Percutaneous adj2 intervention*).tw.   
27 (stent* adj3 (heart or cardiac*)).tw.   
28 (heart valve adj1 (device* or artificial or prosthesis)).tw.   
29 cardiomyopath*.tw.   
30 cardiovascular disease*.tw.   
31 or/1-30   
32 accelerometry/ or actigraphy/ or ambulatory monitor/   
33 exp exercise/ or physical conditioning, human/ or physical fitness/ or Exercise Movement Techniques/  
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34 32 and 33   
35 
(Fitbit or (samsung adj2 gear*) or Vivofit or Vivoactive or Vivosmart or Vivomove or Vivoki or 
garmin* or "Apple watch" or verily or TomTom or "Touch cardio" or "spark cardio" or sensewear 
or activPAL or Actiheart).tw.  
 
36 ((pebble or jawbone) adj6 (activit* or exercis* or wrist* or wear* or track* or monitor* or record* or monitor* or step or steps or stepping)).tw.  
 
37 (polar and (A300 or A360 or M200 or M400 or M430 or M430 or M460 or M600 or V650 or V800 or Loop2)).tw.  
 
38 ("Google fit" or (apple adj6 (health adj6 app)) or FollowMee or RunDouble or C25K or "Couch to 5k" or Endomondo or "sports tracker" or sports-tracker or strava or smartphone*).tw.  
 
39 ((accelerometer* or GPS or actigraph* or actimetr* or "ambulatory monitor*") adj8 (activ* or exercis* or fit or fitness or step or steps or stepping)).tw.  
 
40 ((physical activity or PA or exercis* or step or steps or stepping) adj5 (monitor* or measur* or track* or record*)).tw.  
 
41 smartphone/ or Mobile Applications/   
42 ((app or apps or application*) adj4 (phone* or mobile* or cell*)).tw.   
43 pedometer*.tw.   
44 "fitness track*".tw.   
45 "fitness monitor*".tw.   
46 "activity track*".tw.   
47 ("activity monitor*" or wearable* or "step counter*").tw.   
48 or/34-47   
49 controlled clinical trial.pt.   
50 randomi#ed.ab.   
51 clinical trials as topic.sh.   
52 randomly.ab.   
53 trial.ti.   
54 or/49-53   
55 31 and 48 and 54   
56 limit 55 to yr="2012 -Current"        
 
PsycINFO <1806 to October Week 1 2017> 
# Searches 
1 cardiovascular disorders/     
2 exp heart disorders/     
3 heart surgery/     
4 ((myocardial or cardiac or heart) adj2 (infarct* or isch?emi*)).tw.     
5 (coronary adj2 (syndrome* or disease* or event* or occlusion* or stenos* or thrombo*)).tw.     
6 (myocard* adj2 revasculari?ation).tw.     
7 (STEMI or NSTEMI).tw.     
8 (ST adj2 (elevat* or depress*)).tw.     
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9 "heart transplant*".tw.     
10 angina.tw.     
11 (heart adj2 (failure or attack or bypass or disease*)).tw.     
12 ((heart or cardiac or myocard*) adj2 (fail* or insufficien* or decomp*)).tw.     
13 (HFpEF or HFrEF or left ventricular ejection fraction or ((preserved or reduced) adj ejection fraction)).tw.  
   
14 (LV dysfunction or (diastolic adj (dysfunction* or failure*)) or (systolic adj (dysfunction* or failure*))).tw.  
   
15 pulmonary embolism*.tw.     
16 CABG.tw.     
17 (coronary adj2 bypass).tw.     
18 PTCA.tw.     
19 angioplast*.tw.     
20 PCI.tw.     
21 (Percutaneous adj2 intervention*).tw.     
22 (stent* adj3 (heart or cardiac*)).tw.     
23 (heart valve adj1 (device* or artificial or prosthesis)).tw.     
24 cardiomyopath*.tw.     
25 cardiovascular disease*.tw.     
26 or/1-25     
27 actigraphy/     
28 exercise/ or physical activity/ or physical fitness/     
29 27 and 28     
30 
(Fitbit or (samsung adj2 gear*) or Vivofit or Vivoactive or Vivosmart or Vivomove or Vivoki 
or garmin* or "Apple watch" or verily or TomTom or "Touch cardio" or "spark cardio" or 
sensewear or activPAL or Actiheart).tw.  
   
31 ((pebble or jawbone) adj6 (activit* or exercis* or wrist* or wear* or track* or monitor* or record* or monitor* or step or steps or stepping)).tw.  
   
32 (polar and (A300 or A360 or M200 or M400 or M430 or M430 or M460 or M600 or V650 or V800 or Loop2)).tw.  
   
33 ("Google fit" or (apple adj6 (health adj6 app)) or FollowMee or RunDouble or C25K or "Couch to 5k" or Endomondo or "sports tracker" or sports-tracker or strava or smartphone*).tw.  
   
34 ((accelerometer* or GPS or actigraph* or actimetr* or "ambulatory monitor*") adj8 (activ* or exercis* or fit or fitness or step or steps or stepping)).tw.  
   
35 ((physical activity or PA or exercis* or step or steps or stepping) adj5 (monitor* or measur* or track* or record*)).tw.  
   
36 exp Cellular Phones/ or exp Mobile Devices/     
37 ((app or apps or application*) adj4 (phone* or mobile* or cell*)).tw.     
38 pedometer*.tw.     
39 "fitness track*".tw.     
40 "fitness monitor*".tw.     
41 "activity track*".tw.     
42 ("activity monitor*" or wearable* or "step counter*").tw.     
43 or/29-42     
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44 clinical trials/     
45 randomi#ed.ab.     
46 randomly.ab.     
47 trial.ti.     
48 or/44-47     
49 26 and 43 and 48     
50 limit 49 to yr="2012 -Current"     
 
Scopus 
(TITLE-ABS-KEY(((myocardial OR cardiac OR heart) W/2 (infarct* OR isch?emi*)) OR (coronary 
W/2 (syndrome* OR disease* OR event* OR occlusion* OR stenos* OR thrombo*)) OR (myocard* 
W/2 revasculari?ation) OR STEMI OR NSTEMI OR ("ST" W/2 (elevat* OR depress*)) OR "heart 
transplant*" OR angina OR (heart W/2 (failure OR attack OR bypass OR disease*)) OR ((heart OR 
cardiac OR myocard*) W/2 (fail* OR insufficien* OR decomp*)) OR HFpEF OR HFrEF OR "left 
ventricular ejection fraction" OR ((preserved OR reduced) W/1 "ejection fraction") OR "LV 
dysfunction" OR (diastolic W/1 (dysfunction* OR failure*)) OR (systolic W/1 (dysfunction* OR 
failure*)) OR "pulmonary embolism*" OR CABG OR (coronary W/2 bypass) OR PTCA OR 
angioplast* OR PCI OR (Percutaneous W/2 intervention*) OR (stent* W/3 (heart OR cardiac*)) OR 
("heart valve" W/1 (device* OR artificial OR prosthesis)) OR cardiomyopath* OR "cardiovascular 
disease*")) AND (TITLE-ABS-KEY(Fitbit OR (samsung W/2 gear*) OR Vivofit OR Vivoactive OR 
Vivosmart OR Vivomove OR Vivoki OR garmin* OR "Apple watch" OR verily OR TomTom OR 
"Touch cardio" OR "spark cardio" OR sensewear OR activPAL OR Actiheart OR ((pebble OR 
jawbone) W/6 (activit* OR exercis* OR wrist* OR wear* OR track* OR monitor* OR record* OR 
monitor* OR step OR steps OR stepping)) OR (polar and (A300 OR A360 OR M200 OR M400 OR 
M430 OR M430 OR M460 OR M600 OR V650 OR V800 OR loop2)) OR "Google fit" OR (apple 
W/6 (health W/6 app)) OR FollowMee OR RunDouble OR C25K OR "Couch to 5k" OR Endomondo 
OR "sports tracker" OR "sports-tracker" OR strava OR smartphone* OR ((accelerometer* OR GPS 
OR actigraph* OR actimetr* OR "ambulatory monitor*") W/8 (activ* OR exercis* OR fit OR fitness 
OR step OR steps OR stepping)) OR (("physical activity" OR "PA" OR exercis* OR step OR steps 
OR stepping) W/5 (monitor* OR measur* OR track* OR record*)) OR ((app OR apps OR 
application*) W/4 (phone* OR mobile* OR cell*)) OR pedometer* OR "fitness track*" OR "fitness 
monitor*" OR "activity track*" OR "activity monitor*" OR wearable* OR "step counter*")) AND 
((ABS ( randomi?ed OR randomly ) OR TITLE ( trial )) AND PUBYEAR > 2011) 
 
Cochrane 
((myocardial or cardiac or heart) near/2 (infarct* or isch?emi*)) or (coronary near/2 (syndrome* 
or disease* or event* or occlusion* or stenos* or thrombo*)) or (myocard* near/2 
revasculari?ation) or STEMI or NSTEMI or ("ST" near/2 (elevat* or depress*)) or "heart 
transplant*" or angina or (heart near/2 (failure or attack or bypass or disease*)) or ((heart or 
cardiac or myocard*) near/2 (fail* or insufficien* or decomp*)) or HFpEF or HFrEF or "left 
ventricular ejection fraction" or ((preserved or reduced) near/1 "ejection fraction") or "LV 
dysfunction" or (diastolic near/1 (dysfunction* or failure*)) or (systolic near/1 (dysfunction* or 
failure*)) or "pulmonary embolism*" or CABG or (coronary near/2 bypass) or PTCA or 
angioplast* or PCI or (Percutaneous near/2 intervention*) or (stent* near/3 (heart or cardiac*)) or 
("heart valve" near/1 (device* or artificial or prosthesis)) or cardiomyopath* or "cardiovascular 
disease*":ti,ab,kw and itbit or (samsung near/2 gear*) or Vivofit or Vivoactive or Vivosmart or 
Vivomove or Vivoki or garmin* or "Apple watch" or verily or TomTom or "Touch cardio" or 
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"spark cardio" or sensewear or activPAL or Actiheart or ((pebble or jawbone) near/6 (activit* or 
exercis* or wrist* or wear* or track* or monitor* or record* or monitor* or step or steps or 
stepping)) or (polar and (A300 or A360 or M200 or M400 or M430 or M430 or M460 or M600 or 
V650 or V800 or loop2)) or "Google fit" or (apple near/6 (health near/6 app)) or FollowMee or 
RunDouble or C25K or "Couch to 5k" or Endomondo or "sports tracker" or "sports-tracker" or 
strava or smartphone* or ((accelerometer* or GPS or actigraph* or actimetr* or "ambulatory 
monitor*") near/8 (activ* or exercis* or fit or fitness or step or steps or stepping)) or (("physical 
activity" or "PA" or exercis* or step or steps or stepping) near/5 (monitor* or measur* or track* 
or record*)) or ((app or apps or application*) near/4 (phone* or mobile* or cell*)) or pedometer* 
or "fitness track*" or "fitness monitor*" or "activity track*" or "activity monitor*" or wearable* 
or "step counter*":ti,ab,kw Publication Year from 2012 to 2017 
Web of Science 
TS=(((myocardial OR cardiac OR heart) NEAR/2 (infarct* OR isch?emi*)) OR (coronary NEAR/2 
(syndrome* OR disease* OR event* OR occlusion* OR stenos* OR thrombo*)) OR (myocard* 
NEAR/2 revasculari?ation) OR STEMI OR NSTEMI OR ("ST" NEAR/2 (elevat* OR depress*)) OR 
"heart transplant*" OR angina OR (heart NEAR/2 (failure OR attack OR bypass OR disease*)) OR 
((heart OR cardiac OR myocard*) NEAR/2 (fail* OR insufficien* OR decomp*)) OR HFpEF OR 
HFrEF OR "left ventricular ejection fraction" OR ((preserved OR reduced) NEAR/1 "ejection 
fraction") OR "LV dysfunction" OR (diastolic NEAR/1 (dysfunction* OR failure*)) OR (systolic 
NEAR/1 (dysfunction* OR failure*)) OR "pulmonary embolism*" OR CABG OR (coronary NEAR/2 
bypass) OR PTCA OR angioplast* OR PCI OR (Percutaneous NEAR/2 intervention*) OR (stent* 
NEAR/3 (heart OR cardiac*)) OR ("heart valve" NEAR/1 (device* OR artificial OR prosthesis)) OR 
cardiomyopath* OR "cardiovascular disease*") AND TS=(Fitbit OR (samsung NEAR/2 gear*) OR 
Vivofit OR Vivoactive OR Vivosmart OR Vivomove OR Vivoki OR garmin* OR "Apple watch" OR 
verily OR TomTom OR "Touch cardio" OR "spark cardio" OR sensewear OR activPAL OR Actiheart 
OR ((pebble OR jawbone) NEAR/6 (activit* OR exercis* OR wrist* OR wear* OR track* OR 
monitor* OR record* OR monitor* OR step OR steps OR stepping)) OR (polar and (A300 OR A360 
OR M200 OR M400 OR M430 OR M430 OR M460 OR M600 OR V650 OR V800 OR loop2)) OR 
"Google fit" OR (apple NEAR/6 (health NEAR/6 app)) OR FollowMee OR RunDouble OR C25K 
OR "Couch to 5k" OR Endomondo OR "sports tracker" OR "sports-tracker" OR strava OR 
smartphone* OR ((accelerometer* OR GPS OR actigraph* OR actimetr* OR "ambulatory monitor*") 
NEAR/8 (activ* OR exercis* OR fit OR fitness OR step OR steps OR stepping)) OR (("physical 
activity" OR "PA" OR exercis* OR step OR steps OR stepping) NEAR/5 (monitor* OR measur* OR 
track* OR record*)) OR ((app OR apps OR application*) NEAR/4 (phone* OR mobile* OR cell*)) 
OR pedometer* OR "fitness track*" OR "fitness monitor*" OR "activity track*" OR "activity 
monitor*" OR wearable* OR "step counter*") AND (TI=(trial) OR TS=(randomi?ed OR randomly))  
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH Timespan=2011-2017 
APPENDIX II – EXCLUDED STUDIES 
Study  Reason for exclusion 
Not CVD 
Dasgupta et al. (2014) Not CVD 
Glynn et al. (2014) Not CVD 
Hornbuckle et al. (2012) Not CVD 
Kendzor et al. (2017) Not CVD 
Kraus et al. (2012) Not CVD 
Martin et al. (2015) Not CVD 
Pagels et al. (2012) Not CVD 
Petrella et al. (2014) Not CVD 
Richardson et al. (2016) Not CVD 
van den Berg et al. (2017) Not CVD 
Zhang et al. (2017) Not CVD 
Not an RCT 
Albert et al. (2017) Not RCT and device did not measure PA  
Cheng et al. (2016) Not RCT (does not address outcomes)  
Hannah et al. (2015) Not RCT 
Huffman et al. (2015) Not RCT 
Jehn et al. (2013) Not RCT 
McCarthy et al. (2013) Not RCT 
Pfaeffli et al. (2015) Not RCT (mixed methods research design) 
Ramadi et al. (2016) Not RCT 
Sangster et al. (2017) Not RCT 
Thorup et al. (2016) Not RCT 
Yates et al. (2015) Not RCT 
Zile et al. (2013) Not RCT 
No objective data collected 
Aamot et al. (2012) Device (HR monitor) did not measure levels of PA 
Acanfora et al. (2016) Device did not measure levels of PA 
Almeida et al. (2015) Device not used to monitor physical activity 
Alsaleh et al. (2012) Device not used to measure PA  
Balsam et al. (2013) Device not used to monitor PA 
Barnason et al. (2009) Daily steps from accelerometer self-reported into diary 
Borland et al. (2014) Device (KeepWalking LS2000 pedometer) self-reported log 
Chang et al. (2015). IG kept a daily recording of the number of steps taken 
Chomiuk et al. (2013) No device to measure PA 
Dougherty et al. (2016) Data are transcribed into logs 
Izawa et al. (2012) Patients performed self-monitoring of their physical activity  
Johnston et al. (2016) Device (smartphone-based interactive support tool)  
Lau et al. (2016) Pedometer - recording exercise in an exercise log 
Li et al. (2015) PA duration recorded by participant into a diary 
Midence et al. (2016) Pedometer readings entered into an activity log  
Peterson et al. (2012) Pedometer used to provide feedback and reinforcement  
Reid, Morrin et al. 2012 From the author “From the log book” 
Sangster, Furber et al. (2015) Used pedometer as motivational tools only.  
Salvi, Ottaviano et al. 2017 From author: “study is 10 years old, wearables didn't exist” 
Seto et al. (2012) Device (mobile phone) not used to monitor physical activity 
Varenhorst et al. (2015) Not measuring physical activity 
Wolf et al. (2016) Device (smartphone) does not measure PA 
No device used in study  
Aliabad et al. (2014) No device – questionnaire and treadmill exercise test used 
Abstract/protocol/rationale only 
Anderson et al. (2016) Abstract only – thesis has been retrieved and included 
Bernocchi et al. (2016) Rationale and design only (study not complete) 
Brouwers et al. (2017) Protocol only 
Eastwood et al. (2014) Abstract only. Unable to find study. 
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Edelmann et al. (2017) Rationale and design only (study not complete) 
Kayser et al. (2016) Abstract – protocol only 
Lin et al. (2015) Abstract only. Study requested from author – not received 
Maddison et al. (2014) Protocol only. Resultant study not RCT 
Recio-Rodriguez et al. (2014) Protocol only 
Sangster et al. (2013) Abstract (study included) 
Snoek et al. (2016) Rationale and design only (study not complete) 
Treskes et al. (2017) Rationale and design only (study not complete) 
Varnfield et al. (2012) Abstract only (the RCT: Varnfield 2014 included) 
Yudi et al. (2016) Protocol only 
Duplicate study 
Malmo et al. (2016) Duplicate study 
Walters et al. (2012) Duplicate of Varnfield  
Unable to contact authors 
Frederix, et al. (2015) Unable to contact author re: measurement of PA 
Takase et al. (2015) Insufficient information. No answer from author 
 
 
